
Chronic Pelvic Pain Syndrome, General Conservative and Medical Management and Palmitoylethanolamide (PEA) Efficacy
Author(s) -
Marco Rinaldi
Publication year - 2022
Language(s) - English
DOI - 10.47363/jddt/2022(2)121
Subject(s) - palmitoylethanolamide , medicine , pelvic pain , analgesic , conservative management , medical therapy , quality of life (healthcare) , disease , physical therapy , intensive care medicine , surgery , anesthesia , receptor , nursing , cannabinoid receptor , agonist